logo

TYRA

Tyra Biosciences
--
--(--)
Market Open: --
--
--(--)
Post-Market: --

TYRA Profile

Tyra Biosciences, Inc.

A precision oncology company that developing purpose-built therapies to overcome tumor resistance

Biological Technology
08/02/2018
09/15/2021
NASDAQ Stock Exchange
60
12-31
Common stock
2656 State Street, Carlsbad, CA 92008
--
Tyra Biosciences, Inc., was incorporated in Delaware on August 2, 2018. The company is a precision oncology company focused on developing specialized therapies to overcome tumor resistance and improve treatment outcomes for cancer patients. The company is using its proprietary SNAP platform, which is optimized to rapidly and precisely improve structural design through iterative molecular SNAPshots to generate next-generation product candidates specifically designed to address acquired resistance and provide alternative treatment options.